Rice Hall James & Associates’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Rice Hall James & Associates’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-437,938	Closed	-$20.1M	–	308
2017 Q1	$20.1M	Sell	437,938 -14,777	-3%	-$735K	0.98%	26
2016 Q4	$23.8M	Sell	452,715 -9,321	-2%	-$451K	1.2%	12
2016 Q3	$20.6M	Buy	462,036 +88,947	+24%	+$3.86M	1.08%	21
2016 Q2	$14.2M	Buy	+373,089	New	+$16.4M	0.82%	55

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Rice Hall James & Associates's SYNH Position: Q2 2017 in Review

Rice Hall James & Associates sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2017, closing a stake of 437,938 shares — an estimated $20.1M sold.

Rice Hall James & Associates first reported a position in SYNH in Q2 2016 and held it in 4 quarters. The position peaked at $23.8M in Q4 2016. 247 funds tracked by Wall St. Rank hold SYNH as of Q2 2017.

Rice Hall James & Associates reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2017 after selling out during the quarter.
Rice Hall James & Associates sold 437,938 Syneos Health, Inc. Class A Common Stock shares in Q2 2017, an estimated $20.1M.
Rice Hall James & Associates first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2016 and held it in 4 quarters.
Rice Hall James & Associates's Syneos Health, Inc. Class A Common Stock position peaked at $23.8M in Q4 2016.
247 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2017.

Based on Rice Hall James & Associates's 13F filing for Q2 2017, filed 2 Aug 2017.